Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'

Discussion (3 Comments)Read Original on HackerNews

randycupertino•about 2 hours ago

Incredibly stupid this is allowed and will become an avenue for rampant insider trading by biotech employees.

Look at the recent ChemoCentryx fraud where they settled for $35 million over misleading data and overstating results. This is going to encourage even more data manipulation.

OneLeggedCat•about 1 hour ago

> rampant insider trading by biotech employees

It also provides a big incentive for sabotage.

quantified•36 minutes ago

This is one of the huge problems with allowing betting. Of course, people could collude without the formal marketplace, but just as social media provides really painful detrimental cons along with its pros, so do betting platforms.

OsrsNeedsf2P•about 2 hours ago

Given how much pressure there is to rig results with these markets, I see this going well.

alex43578•8 minutes ago

If the hundreds of millions of dollars attached to the outcome doesn’t already create that pressure, tens of thousands connected to the prediction market won’t matter.

verdverm•about 2 hours ago

I can only imagine the company culture that enables and encourages creating gambling opportunities for this and the other troubling worldly events

Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'

⚡ Community Insights

Discussion (3 Comments)Read Original on HackerNews